nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP2D6—breast cancer	0.175	0.583	CbGaD
Desloratadine—ABCB1—breast cancer	0.125	0.417	CbGaD
Desloratadine—CYP1A2—Anastrozole—breast cancer	0.0405	0.0878	CbGbCtD
Desloratadine—CYP1A2—Toremifene—breast cancer	0.037	0.0803	CbGbCtD
Desloratadine—CYP2C9—Anastrozole—breast cancer	0.0365	0.0791	CbGbCtD
Desloratadine—ABCB1—Toremifene—breast cancer	0.0324	0.0702	CbGbCtD
Desloratadine—CYP2C19—Lapatinib—breast cancer	0.0293	0.0635	CbGbCtD
Desloratadine—CYP2C9—Idarubicin—breast cancer	0.0277	0.0599	CbGbCtD
Desloratadine—CYP2D6—Idarubicin—breast cancer	0.0253	0.0548	CbGbCtD
Desloratadine—ABCB1—Lapatinib—breast cancer	0.0236	0.0512	CbGbCtD
Desloratadine—CYP2C9—Capecitabine—breast cancer	0.0152	0.0328	CbGbCtD
Desloratadine—CYP2C19—Tamoxifen—breast cancer	0.0147	0.0318	CbGbCtD
Desloratadine—CYP1A2—Tamoxifen—breast cancer	0.0135	0.0293	CbGbCtD
Desloratadine—ABCB1—Vinorelbine—breast cancer	0.0131	0.0284	CbGbCtD
Desloratadine—CYP2D6—Vinorelbine—breast cancer	0.0123	0.0268	CbGbCtD
Desloratadine—CYP2C9—Tamoxifen—breast cancer	0.0122	0.0264	CbGbCtD
Desloratadine—ABCB1—Tamoxifen—breast cancer	0.0118	0.0256	CbGbCtD
Desloratadine—ABCB1—Mitoxantrone—breast cancer	0.0115	0.025	CbGbCtD
Desloratadine—CYP2D6—Tamoxifen—breast cancer	0.0111	0.0242	CbGbCtD
Desloratadine—ABCB1—Gemcitabine—breast cancer	0.0102	0.0221	CbGbCtD
Desloratadine—CYP1A2—Fluorouracil—breast cancer	0.00997	0.0216	CbGbCtD
Desloratadine—CYP2C9—Paclitaxel—breast cancer	0.00949	0.0206	CbGbCtD
Desloratadine—ABCB1—Paclitaxel—breast cancer	0.00921	0.02	CbGbCtD
Desloratadine—ABCB1—Irinotecan—breast cancer	0.00908	0.0197	CbGbCtD
Desloratadine—CYP2C9—Fluorouracil—breast cancer	0.00898	0.0195	CbGbCtD
Desloratadine—ABCB1—Vinblastine—breast cancer	0.00808	0.0175	CbGbCtD
Desloratadine—CYP2D6—Vinblastine—breast cancer	0.00761	0.0165	CbGbCtD
Desloratadine—ABCB1—Docetaxel—breast cancer	0.00666	0.0144	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—breast cancer	0.00496	0.0108	CbGbCtD
Desloratadine—ABCB1—Methotrexate—breast cancer	0.00481	0.0104	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—breast cancer	0.00468	0.0101	CbGbCtD
Desloratadine—Loratadine—CYP2D6—breast cancer	0.000459	0.261	CrCbGaD
Desloratadine—Azatadine—CYP3A4—breast cancer	0.000416	0.236	CrCbGaD
Desloratadine—Loratadine—CYP3A4—breast cancer	0.000394	0.224	CrCbGaD
Desloratadine—Loratadine—ABCB1—breast cancer	0.000328	0.186	CrCbGaD
Desloratadine—Amoxapine—CYP2D6—breast cancer	0.000165	0.0936	CrCbGaD
Desloratadine—Cough—Docetaxel—breast cancer	8.98e-05	0.00053	CcSEcCtD
Desloratadine—Hepatobiliary disease—Methotrexate—breast cancer	8.97e-05	0.00053	CcSEcCtD
Desloratadine—Insomnia—Paclitaxel—breast cancer	8.96e-05	0.000529	CcSEcCtD
Desloratadine—Epistaxis—Methotrexate—breast cancer	8.95e-05	0.000529	CcSEcCtD
Desloratadine—Hypersensitivity—Mitoxantrone—breast cancer	8.95e-05	0.000529	CcSEcCtD
Desloratadine—Hypersensitivity—Irinotecan—breast cancer	8.95e-05	0.000529	CcSEcCtD
Desloratadine—Vomiting—Thiotepa—breast cancer	8.94e-05	0.000528	CcSEcCtD
Desloratadine—Convulsion—Docetaxel—breast cancer	8.91e-05	0.000527	CcSEcCtD
Desloratadine—Infestation—Epirubicin—breast cancer	8.88e-05	0.000525	CcSEcCtD
Desloratadine—Infestation NOS—Epirubicin—breast cancer	8.88e-05	0.000525	CcSEcCtD
Desloratadine—Rash—Thiotepa—breast cancer	8.87e-05	0.000524	CcSEcCtD
Desloratadine—Bronchitis—Doxorubicin—breast cancer	8.86e-05	0.000524	CcSEcCtD
Desloratadine—Dermatitis—Thiotepa—breast cancer	8.86e-05	0.000523	CcSEcCtD
Desloratadine—Dyspnoea—Paclitaxel—breast cancer	8.83e-05	0.000522	CcSEcCtD
Desloratadine—Headache—Thiotepa—breast cancer	8.81e-05	0.000521	CcSEcCtD
Desloratadine—Somnolence—Paclitaxel—breast cancer	8.81e-05	0.00052	CcSEcCtD
Desloratadine—Palpitations—Capecitabine—breast cancer	8.8e-05	0.00052	CcSEcCtD
Desloratadine—Myalgia—Docetaxel—breast cancer	8.76e-05	0.000517	CcSEcCtD
Desloratadine—Nausea—Vinorelbine—breast cancer	8.75e-05	0.000517	CcSEcCtD
Desloratadine—Dyspepsia—Paclitaxel—breast cancer	8.72e-05	0.000515	CcSEcCtD
Desloratadine—Asthenia—Irinotecan—breast cancer	8.71e-05	0.000515	CcSEcCtD
Desloratadine—Asthenia—Mitoxantrone—breast cancer	8.71e-05	0.000515	CcSEcCtD
Desloratadine—Cough—Capecitabine—breast cancer	8.69e-05	0.000514	CcSEcCtD
Desloratadine—Urinary tract infection—Epirubicin—breast cancer	8.63e-05	0.00051	CcSEcCtD
Desloratadine—Decreased appetite—Paclitaxel—breast cancer	8.61e-05	0.000509	CcSEcCtD
Desloratadine—Hypersensitivity—Fluorouracil—breast cancer	8.57e-05	0.000506	CcSEcCtD
Desloratadine—Dry mouth—Docetaxel—breast cancer	8.57e-05	0.000506	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Doxorubicin—breast cancer	8.56e-05	0.000506	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Paclitaxel—breast cancer	8.55e-05	0.000505	CcSEcCtD
Desloratadine—Fatigue—Paclitaxel—breast cancer	8.54e-05	0.000505	CcSEcCtD
Desloratadine—Hepatitis—Methotrexate—breast cancer	8.52e-05	0.000503	CcSEcCtD
Desloratadine—Asthenia—Gemcitabine—breast cancer	8.49e-05	0.000502	CcSEcCtD
Desloratadine—Myalgia—Capecitabine—breast cancer	8.48e-05	0.000501	CcSEcCtD
Desloratadine—Pharyngitis—Methotrexate—breast cancer	8.45e-05	0.000499	CcSEcCtD
Desloratadine—Hepatobiliary disease—Epirubicin—breast cancer	8.4e-05	0.000496	CcSEcCtD
Desloratadine—Oedema—Docetaxel—breast cancer	8.4e-05	0.000496	CcSEcCtD
Desloratadine—Anaphylactic shock—Docetaxel—breast cancer	8.4e-05	0.000496	CcSEcCtD
Desloratadine—Epistaxis—Epirubicin—breast cancer	8.37e-05	0.000495	CcSEcCtD
Desloratadine—Pruritus—Gemcitabine—breast cancer	8.37e-05	0.000495	CcSEcCtD
Desloratadine—Nausea—Thiotepa—breast cancer	8.35e-05	0.000494	CcSEcCtD
Desloratadine—Infection—Docetaxel—breast cancer	8.34e-05	0.000493	CcSEcCtD
Desloratadine—Diarrhoea—Mitoxantrone—breast cancer	8.31e-05	0.000491	CcSEcCtD
Desloratadine—Diarrhoea—Irinotecan—breast cancer	8.31e-05	0.000491	CcSEcCtD
Desloratadine—Dry mouth—Capecitabine—breast cancer	8.29e-05	0.00049	CcSEcCtD
Desloratadine—Nervous system disorder—Docetaxel—breast cancer	8.23e-05	0.000486	CcSEcCtD
Desloratadine—Pruritus—Fluorouracil—breast cancer	8.23e-05	0.000486	CcSEcCtD
Desloratadine—Infestation—Doxorubicin—breast cancer	8.22e-05	0.000485	CcSEcCtD
Desloratadine—Infestation NOS—Doxorubicin—breast cancer	8.22e-05	0.000485	CcSEcCtD
Desloratadine—Tachycardia—Docetaxel—breast cancer	8.19e-05	0.000484	CcSEcCtD
Desloratadine—Oedema—Capecitabine—breast cancer	8.13e-05	0.00048	CcSEcCtD
Desloratadine—Gastrointestinal pain—Paclitaxel—breast cancer	8.1e-05	0.000479	CcSEcCtD
Desloratadine—Diarrhoea—Gemcitabine—breast cancer	8.09e-05	0.000478	CcSEcCtD
Desloratadine—Infection—Capecitabine—breast cancer	8.08e-05	0.000477	CcSEcCtD
Desloratadine—Dizziness—Irinotecan—breast cancer	8.03e-05	0.000475	CcSEcCtD
Desloratadine—Anorexia—Docetaxel—breast cancer	8e-05	0.000473	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—breast cancer	7.99e-05	0.000472	CcSEcCtD
Desloratadine—Nervous system disorder—Capecitabine—breast cancer	7.97e-05	0.000471	CcSEcCtD
Desloratadine—Hepatitis—Epirubicin—breast cancer	7.97e-05	0.000471	CcSEcCtD
Desloratadine—Diarrhoea—Fluorouracil—breast cancer	7.96e-05	0.00047	CcSEcCtD
Desloratadine—Tachycardia—Capecitabine—breast cancer	7.93e-05	0.000469	CcSEcCtD
Desloratadine—Pharyngitis—Epirubicin—breast cancer	7.91e-05	0.000467	CcSEcCtD
Desloratadine—Cardiac disorder—Methotrexate—breast cancer	7.9e-05	0.000467	CcSEcCtD
Desloratadine—Urticaria—Paclitaxel—breast cancer	7.87e-05	0.000465	CcSEcCtD
Desloratadine—Connective tissue disorder—Epirubicin—breast cancer	7.83e-05	0.000463	CcSEcCtD
Desloratadine—Body temperature increased—Paclitaxel—breast cancer	7.83e-05	0.000463	CcSEcCtD
Desloratadine—Abdominal pain—Paclitaxel—breast cancer	7.83e-05	0.000463	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—breast cancer	7.77e-05	0.000459	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—breast cancer	7.75e-05	0.000458	CcSEcCtD
Desloratadine—Anorexia—Capecitabine—breast cancer	7.75e-05	0.000458	CcSEcCtD
Desloratadine—Vomiting—Mitoxantrone—breast cancer	7.72e-05	0.000456	CcSEcCtD
Desloratadine—Vomiting—Irinotecan—breast cancer	7.72e-05	0.000456	CcSEcCtD
Desloratadine—Dizziness—Fluorouracil—breast cancer	7.69e-05	0.000454	CcSEcCtD
Desloratadine—Rash—Mitoxantrone—breast cancer	7.66e-05	0.000452	CcSEcCtD
Desloratadine—Rash—Irinotecan—breast cancer	7.66e-05	0.000452	CcSEcCtD
Desloratadine—Dermatitis—Irinotecan—breast cancer	7.65e-05	0.000452	CcSEcCtD
Desloratadine—Dermatitis—Mitoxantrone—breast cancer	7.65e-05	0.000452	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Docetaxel—breast cancer	7.65e-05	0.000452	CcSEcCtD
Desloratadine—Headache—Irinotecan—breast cancer	7.61e-05	0.00045	CcSEcCtD
Desloratadine—Headache—Mitoxantrone—breast cancer	7.61e-05	0.00045	CcSEcCtD
Desloratadine—Insomnia—Docetaxel—breast cancer	7.59e-05	0.000449	CcSEcCtD
Desloratadine—Vomiting—Gemcitabine—breast cancer	7.52e-05	0.000444	CcSEcCtD
Desloratadine—Dyspnoea—Docetaxel—breast cancer	7.49e-05	0.000442	CcSEcCtD
Desloratadine—Somnolence—Docetaxel—breast cancer	7.46e-05	0.000441	CcSEcCtD
Desloratadine—Mental disorder—Methotrexate—breast cancer	7.46e-05	0.000441	CcSEcCtD
Desloratadine—Rash—Gemcitabine—breast cancer	7.46e-05	0.000441	CcSEcCtD
Desloratadine—Dermatitis—Gemcitabine—breast cancer	7.45e-05	0.00044	CcSEcCtD
Desloratadine—Erythema—Methotrexate—breast cancer	7.41e-05	0.000438	CcSEcCtD
Desloratadine—Headache—Gemcitabine—breast cancer	7.41e-05	0.000438	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Capecitabine—breast cancer	7.41e-05	0.000438	CcSEcCtD
Desloratadine—Cardiac disorder—Epirubicin—breast cancer	7.4e-05	0.000437	CcSEcCtD
Desloratadine—Vomiting—Fluorouracil—breast cancer	7.4e-05	0.000437	CcSEcCtD
Desloratadine—Dyspepsia—Docetaxel—breast cancer	7.39e-05	0.000437	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—breast cancer	7.38e-05	0.000436	CcSEcCtD
Desloratadine—Insomnia—Capecitabine—breast cancer	7.35e-05	0.000434	CcSEcCtD
Desloratadine—Rash—Fluorouracil—breast cancer	7.33e-05	0.000433	CcSEcCtD
Desloratadine—Dermatitis—Fluorouracil—breast cancer	7.33e-05	0.000433	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—breast cancer	7.32e-05	0.000432	CcSEcCtD
Desloratadine—Decreased appetite—Docetaxel—breast cancer	7.3e-05	0.000431	CcSEcCtD
Desloratadine—Hypersensitivity—Paclitaxel—breast cancer	7.3e-05	0.000431	CcSEcCtD
Desloratadine—Headache—Fluorouracil—breast cancer	7.29e-05	0.000431	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Docetaxel—breast cancer	7.25e-05	0.000428	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—breast cancer	7.25e-05	0.000428	CcSEcCtD
Desloratadine—Dyspnoea—Capecitabine—breast cancer	7.25e-05	0.000428	CcSEcCtD
Desloratadine—Fatigue—Docetaxel—breast cancer	7.24e-05	0.000428	CcSEcCtD
Desloratadine—Nausea—Irinotecan—breast cancer	7.21e-05	0.000426	CcSEcCtD
Desloratadine—Nausea—Mitoxantrone—breast cancer	7.21e-05	0.000426	CcSEcCtD
Desloratadine—Dyspepsia—Capecitabine—breast cancer	7.16e-05	0.000423	CcSEcCtD
Desloratadine—Asthenia—Paclitaxel—breast cancer	7.11e-05	0.00042	CcSEcCtD
Desloratadine—Decreased appetite—Capecitabine—breast cancer	7.07e-05	0.000417	CcSEcCtD
Desloratadine—Nausea—Gemcitabine—breast cancer	7.03e-05	0.000415	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Capecitabine—breast cancer	7.02e-05	0.000415	CcSEcCtD
Desloratadine—Fatigue—Capecitabine—breast cancer	7.01e-05	0.000414	CcSEcCtD
Desloratadine—Pruritus—Paclitaxel—breast cancer	7.01e-05	0.000414	CcSEcCtD
Desloratadine—Mental disorder—Epirubicin—breast cancer	6.98e-05	0.000413	CcSEcCtD
Desloratadine—Erythema—Epirubicin—breast cancer	6.94e-05	0.00041	CcSEcCtD
Desloratadine—Nausea—Fluorouracil—breast cancer	6.91e-05	0.000408	CcSEcCtD
Desloratadine—Gastrointestinal pain—Docetaxel—breast cancer	6.87e-05	0.000406	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—breast cancer	6.84e-05	0.000404	CcSEcCtD
Desloratadine—Diarrhoea—Paclitaxel—breast cancer	6.78e-05	0.0004	CcSEcCtD
Desloratadine—Gastrointestinal pain—Capecitabine—breast cancer	6.65e-05	0.000393	CcSEcCtD
Desloratadine—Abdominal pain—Docetaxel—breast cancer	6.64e-05	0.000392	CcSEcCtD
Desloratadine—Body temperature increased—Docetaxel—breast cancer	6.64e-05	0.000392	CcSEcCtD
Desloratadine—Dizziness—Paclitaxel—breast cancer	6.55e-05	0.000387	CcSEcCtD
Desloratadine—Cough—Methotrexate—breast cancer	6.47e-05	0.000382	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—breast cancer	6.46e-05	0.000382	CcSEcCtD
Desloratadine—Urticaria—Capecitabine—breast cancer	6.46e-05	0.000382	CcSEcCtD
Desloratadine—Body temperature increased—Capecitabine—breast cancer	6.43e-05	0.00038	CcSEcCtD
Desloratadine—Abdominal pain—Capecitabine—breast cancer	6.43e-05	0.00038	CcSEcCtD
Desloratadine—Convulsion—Methotrexate—breast cancer	6.42e-05	0.00038	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—breast cancer	6.42e-05	0.000379	CcSEcCtD
Desloratadine—Agitation—Epirubicin—breast cancer	6.38e-05	0.000377	CcSEcCtD
Desloratadine—Myalgia—Methotrexate—breast cancer	6.31e-05	0.000373	CcSEcCtD
Desloratadine—Vomiting—Paclitaxel—breast cancer	6.3e-05	0.000372	CcSEcCtD
Desloratadine—Rash—Paclitaxel—breast cancer	6.25e-05	0.000369	CcSEcCtD
Desloratadine—Dermatitis—Paclitaxel—breast cancer	6.24e-05	0.000369	CcSEcCtD
Desloratadine—Headache—Paclitaxel—breast cancer	6.21e-05	0.000367	CcSEcCtD
Desloratadine—Hypersensitivity—Docetaxel—breast cancer	6.19e-05	0.000365	CcSEcCtD
Desloratadine—Palpitations—Epirubicin—breast cancer	6.13e-05	0.000362	CcSEcCtD
Desloratadine—Cough—Epirubicin—breast cancer	6.05e-05	0.000358	CcSEcCtD
Desloratadine—Anaphylactic shock—Methotrexate—breast cancer	6.05e-05	0.000358	CcSEcCtD
Desloratadine—Asthenia—Docetaxel—breast cancer	6.02e-05	0.000356	CcSEcCtD
Desloratadine—Convulsion—Epirubicin—breast cancer	6.01e-05	0.000355	CcSEcCtD
Desloratadine—Infection—Methotrexate—breast cancer	6.01e-05	0.000355	CcSEcCtD
Desloratadine—Hypersensitivity—Capecitabine—breast cancer	5.99e-05	0.000354	CcSEcCtD
Desloratadine—Pruritus—Docetaxel—breast cancer	5.94e-05	0.000351	CcSEcCtD
Desloratadine—Nervous system disorder—Methotrexate—breast cancer	5.93e-05	0.000351	CcSEcCtD
Desloratadine—Myalgia—Epirubicin—breast cancer	5.91e-05	0.000349	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—breast cancer	5.9e-05	0.000349	CcSEcCtD
Desloratadine—Nausea—Paclitaxel—breast cancer	5.88e-05	0.000348	CcSEcCtD
Desloratadine—Asthenia—Capecitabine—breast cancer	5.83e-05	0.000345	CcSEcCtD
Desloratadine—Dry mouth—Epirubicin—breast cancer	5.78e-05	0.000341	CcSEcCtD
Desloratadine—Anorexia—Methotrexate—breast cancer	5.77e-05	0.000341	CcSEcCtD
Desloratadine—Pruritus—Capecitabine—breast cancer	5.75e-05	0.00034	CcSEcCtD
Desloratadine—Diarrhoea—Docetaxel—breast cancer	5.74e-05	0.000339	CcSEcCtD
Desloratadine—Palpitations—Doxorubicin—breast cancer	5.67e-05	0.000335	CcSEcCtD
Desloratadine—Oedema—Epirubicin—breast cancer	5.66e-05	0.000335	CcSEcCtD
Desloratadine—Anaphylactic shock—Epirubicin—breast cancer	5.66e-05	0.000335	CcSEcCtD
Desloratadine—Infection—Epirubicin—breast cancer	5.63e-05	0.000332	CcSEcCtD
Desloratadine—Cough—Doxorubicin—breast cancer	5.6e-05	0.000331	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—breast cancer	5.56e-05	0.000329	CcSEcCtD
Desloratadine—Diarrhoea—Capecitabine—breast cancer	5.56e-05	0.000329	CcSEcCtD
Desloratadine—Nervous system disorder—Epirubicin—breast cancer	5.55e-05	0.000328	CcSEcCtD
Desloratadine—Dizziness—Docetaxel—breast cancer	5.55e-05	0.000328	CcSEcCtD
Desloratadine—Tachycardia—Epirubicin—breast cancer	5.53e-05	0.000327	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Methotrexate—breast cancer	5.51e-05	0.000326	CcSEcCtD
Desloratadine—Insomnia—Methotrexate—breast cancer	5.47e-05	0.000323	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—breast cancer	5.47e-05	0.000323	CcSEcCtD
Desloratadine—Anorexia—Epirubicin—breast cancer	5.4e-05	0.000319	CcSEcCtD
Desloratadine—Dyspnoea—Methotrexate—breast cancer	5.39e-05	0.000319	CcSEcCtD
Desloratadine—Somnolence—Methotrexate—breast cancer	5.38e-05	0.000318	CcSEcCtD
Desloratadine—Dizziness—Capecitabine—breast cancer	5.38e-05	0.000318	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—breast cancer	5.35e-05	0.000316	CcSEcCtD
Desloratadine—Vomiting—Docetaxel—breast cancer	5.34e-05	0.000315	CcSEcCtD
Desloratadine—Dyspepsia—Methotrexate—breast cancer	5.33e-05	0.000315	CcSEcCtD
Desloratadine—Rash—Docetaxel—breast cancer	5.29e-05	0.000313	CcSEcCtD
Desloratadine—Dermatitis—Docetaxel—breast cancer	5.29e-05	0.000312	CcSEcCtD
Desloratadine—Decreased appetite—Methotrexate—breast cancer	5.26e-05	0.000311	CcSEcCtD
Desloratadine—Headache—Docetaxel—breast cancer	5.26e-05	0.000311	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—breast cancer	5.24e-05	0.00031	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—breast cancer	5.24e-05	0.00031	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Methotrexate—breast cancer	5.22e-05	0.000309	CcSEcCtD
Desloratadine—Fatigue—Methotrexate—breast cancer	5.22e-05	0.000308	CcSEcCtD
Desloratadine—Infection—Doxorubicin—breast cancer	5.21e-05	0.000308	CcSEcCtD
Desloratadine—Vomiting—Capecitabine—breast cancer	5.17e-05	0.000305	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Epirubicin—breast cancer	5.16e-05	0.000305	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—breast cancer	5.14e-05	0.000304	CcSEcCtD
Desloratadine—Rash—Capecitabine—breast cancer	5.13e-05	0.000303	CcSEcCtD
Desloratadine—Insomnia—Epirubicin—breast cancer	5.12e-05	0.000303	CcSEcCtD
Desloratadine—Dermatitis—Capecitabine—breast cancer	5.12e-05	0.000303	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—breast cancer	5.11e-05	0.000302	CcSEcCtD
Desloratadine—Headache—Capecitabine—breast cancer	5.09e-05	0.000301	CcSEcCtD
Desloratadine—Dyspnoea—Epirubicin—breast cancer	5.05e-05	0.000298	CcSEcCtD
Desloratadine—Somnolence—Epirubicin—breast cancer	5.03e-05	0.000297	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—breast cancer	4.99e-05	0.000295	CcSEcCtD
Desloratadine—Nausea—Docetaxel—breast cancer	4.99e-05	0.000295	CcSEcCtD
Desloratadine—Dyspepsia—Epirubicin—breast cancer	4.98e-05	0.000295	CcSEcCtD
Desloratadine—Gastrointestinal pain—Methotrexate—breast cancer	4.95e-05	0.000292	CcSEcCtD
Desloratadine—Decreased appetite—Epirubicin—breast cancer	4.92e-05	0.000291	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Epirubicin—breast cancer	4.89e-05	0.000289	CcSEcCtD
Desloratadine—Fatigue—Epirubicin—breast cancer	4.88e-05	0.000288	CcSEcCtD
Desloratadine—Nausea—Capecitabine—breast cancer	4.83e-05	0.000285	CcSEcCtD
Desloratadine—Urticaria—Methotrexate—breast cancer	4.81e-05	0.000284	CcSEcCtD
Desloratadine—Abdominal pain—Methotrexate—breast cancer	4.78e-05	0.000283	CcSEcCtD
Desloratadine—Body temperature increased—Methotrexate—breast cancer	4.78e-05	0.000283	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.77e-05	0.000282	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—breast cancer	4.74e-05	0.00028	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—breast cancer	4.67e-05	0.000276	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—breast cancer	4.66e-05	0.000275	CcSEcCtD
Desloratadine—Gastrointestinal pain—Epirubicin—breast cancer	4.63e-05	0.000274	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—breast cancer	4.61e-05	0.000273	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—breast cancer	4.55e-05	0.000269	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—breast cancer	4.52e-05	0.000267	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—breast cancer	4.52e-05	0.000267	CcSEcCtD
Desloratadine—Urticaria—Epirubicin—breast cancer	4.5e-05	0.000266	CcSEcCtD
Desloratadine—Abdominal pain—Epirubicin—breast cancer	4.48e-05	0.000264	CcSEcCtD
Desloratadine—Body temperature increased—Epirubicin—breast cancer	4.48e-05	0.000264	CcSEcCtD
Desloratadine—Hypersensitivity—Methotrexate—breast cancer	4.46e-05	0.000263	CcSEcCtD
Desloratadine—Asthenia—Methotrexate—breast cancer	4.34e-05	0.000257	CcSEcCtD
Desloratadine—Gastrointestinal pain—Doxorubicin—breast cancer	4.28e-05	0.000253	CcSEcCtD
Desloratadine—Pruritus—Methotrexate—breast cancer	4.28e-05	0.000253	CcSEcCtD
Desloratadine—Hypersensitivity—Epirubicin—breast cancer	4.17e-05	0.000247	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—breast cancer	4.16e-05	0.000246	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—breast cancer	4.14e-05	0.000245	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—breast cancer	4.14e-05	0.000245	CcSEcCtD
Desloratadine—Diarrhoea—Methotrexate—breast cancer	4.14e-05	0.000245	CcSEcCtD
Desloratadine—Asthenia—Epirubicin—breast cancer	4.06e-05	0.00024	CcSEcCtD
Desloratadine—Pruritus—Epirubicin—breast cancer	4.01e-05	0.000237	CcSEcCtD
Desloratadine—Dizziness—Methotrexate—breast cancer	4e-05	0.000236	CcSEcCtD
Desloratadine—Diarrhoea—Epirubicin—breast cancer	3.87e-05	0.000229	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—breast cancer	3.86e-05	0.000228	CcSEcCtD
Desloratadine—Vomiting—Methotrexate—breast cancer	3.85e-05	0.000227	CcSEcCtD
Desloratadine—Rash—Methotrexate—breast cancer	3.82e-05	0.000225	CcSEcCtD
Desloratadine—Dermatitis—Methotrexate—breast cancer	3.81e-05	0.000225	CcSEcCtD
Desloratadine—Headache—Methotrexate—breast cancer	3.79e-05	0.000224	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—breast cancer	3.76e-05	0.000222	CcSEcCtD
Desloratadine—Dizziness—Epirubicin—breast cancer	3.74e-05	0.000221	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—breast cancer	3.71e-05	0.000219	CcSEcCtD
Desloratadine—Vomiting—Epirubicin—breast cancer	3.6e-05	0.000213	CcSEcCtD
Desloratadine—Nausea—Methotrexate—breast cancer	3.59e-05	0.000212	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—breast cancer	3.59e-05	0.000212	CcSEcCtD
Desloratadine—Rash—Epirubicin—breast cancer	3.57e-05	0.000211	CcSEcCtD
Desloratadine—Dermatitis—Epirubicin—breast cancer	3.57e-05	0.000211	CcSEcCtD
Desloratadine—Headache—Epirubicin—breast cancer	3.55e-05	0.00021	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—breast cancer	3.46e-05	0.000205	CcSEcCtD
Desloratadine—Nausea—Epirubicin—breast cancer	3.36e-05	0.000199	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—breast cancer	3.33e-05	0.000197	CcSEcCtD
Desloratadine—Rash—Doxorubicin—breast cancer	3.3e-05	0.000195	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—breast cancer	3.3e-05	0.000195	CcSEcCtD
Desloratadine—Headache—Doxorubicin—breast cancer	3.28e-05	0.000194	CcSEcCtD
Desloratadine—Nausea—Doxorubicin—breast cancer	3.11e-05	0.000184	CcSEcCtD
Desloratadine—HRH1—Signaling Pathways—NRG1—breast cancer	5.83e-06	8.71e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.81e-06	8.67e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—FASN—breast cancer	5.8e-06	8.66e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—H2AFX—breast cancer	5.79e-06	8.64e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HPGDS—breast cancer	5.79e-06	8.64e-05	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—breast cancer	5.79e-06	8.64e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—BCHE—breast cancer	5.77e-06	8.62e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HBA1—breast cancer	5.75e-06	8.59e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—E2F1—breast cancer	5.75e-06	8.58e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—FASN—breast cancer	5.75e-06	8.58e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1B1—breast cancer	5.74e-06	8.57e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—BCHE—breast cancer	5.72e-06	8.54e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CB—breast cancer	5.72e-06	8.54e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SLC5A5—breast cancer	5.7e-06	8.51e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP3A4—breast cancer	5.7e-06	8.51e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SLC5A5—breast cancer	5.65e-06	8.44e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—HSP90AA1—breast cancer	5.63e-06	8.41e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ACHE—breast cancer	5.61e-06	8.38e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTT1—breast cancer	5.61e-06	8.38e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1B1—breast cancer	5.6e-06	8.37e-05	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	5.57e-06	8.32e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SPP1—breast cancer	5.52e-06	8.25e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—SLC2A1—breast cancer	5.51e-06	8.22e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NQO1—breast cancer	5.51e-06	8.22e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—CXCL8—breast cancer	5.5e-06	8.21e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—HSP90AA1—breast cancer	5.49e-06	8.2e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NCOA1—breast cancer	5.48e-06	8.18e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB3—breast cancer	5.46e-06	8.16e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—SLC2A1—breast cancer	5.46e-06	8.15e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NQO1—breast cancer	5.46e-06	8.15e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGFR2—breast cancer	5.45e-06	8.14e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—STK11—breast cancer	5.4e-06	8.06e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP19A1—breast cancer	5.4e-06	8.06e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP3A4—breast cancer	5.37e-06	8.02e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.35e-06	7.98e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NCOA1—breast cancer	5.34e-06	7.98e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP3A4—breast cancer	5.32e-06	7.95e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP17A1—breast cancer	5.31e-06	7.93e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.3e-06	7.91e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1B1—breast cancer	5.28e-06	7.88e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—STK11—breast cancer	5.27e-06	7.87e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP19A1—breast cancer	5.27e-06	7.87e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ENO1—breast cancer	5.26e-06	7.85e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS1—breast cancer	5.26e-06	7.85e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—breast cancer	5.25e-06	7.85e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.24e-06	7.83e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TERT—breast cancer	5.23e-06	7.82e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1B1—breast cancer	5.23e-06	7.82e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HSP90AA1—breast cancer	5.18e-06	7.73e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.17e-06	7.73e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP2D6—breast cancer	5.16e-06	7.7e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HSP90AA1—breast cancer	5.13e-06	7.66e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FGFR1—breast cancer	5.08e-06	7.59e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.07e-06	7.56e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NCOA2—breast cancer	5.06e-06	7.56e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NCOA1—breast cancer	5.04e-06	7.52e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—COMT—breast cancer	5.02e-06	7.49e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HIF1A—breast cancer	5.01e-06	7.48e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTP1—breast cancer	4.99e-06	7.46e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NCOA1—breast cancer	4.99e-06	7.46e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—STK11—breast cancer	4.96e-06	7.41e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP19A1—breast cancer	4.96e-06	7.41e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—HMOX1—breast cancer	4.92e-06	7.35e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—STK11—breast cancer	4.92e-06	7.35e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP19A1—breast cancer	4.92e-06	7.35e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ITPR1—breast cancer	4.91e-06	7.34e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—FASN—breast cancer	4.91e-06	7.33e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—COMT—breast cancer	4.9e-06	7.31e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—BCHE—breast cancer	4.89e-06	7.3e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—LEP—breast cancer	4.89e-06	7.3e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTP1—breast cancer	4.87e-06	7.28e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CAV1—breast cancer	4.84e-06	7.23e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SLC5A5—breast cancer	4.83e-06	7.21e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—HMOX1—breast cancer	4.81e-06	7.18e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ITPR1—breast cancer	4.8e-06	7.16e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KDR—breast cancer	4.79e-06	7.15e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ABCB1—breast cancer	4.73e-06	7.06e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ESR1—breast cancer	4.67e-06	6.97e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NQO1—breast cancer	4.66e-06	6.97e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—SLC2A1—breast cancer	4.66e-06	6.97e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—TYMS—breast cancer	4.64e-06	6.93e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.62e-06	6.9e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—COMT—breast cancer	4.61e-06	6.89e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—FN1—breast cancer	4.61e-06	6.88e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTP1—breast cancer	4.59e-06	6.86e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PLA2G4A—breast cancer	4.59e-06	6.85e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—breast cancer	4.59e-06	6.85e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NCOR1—breast cancer	4.59e-06	6.85e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—COMT—breast cancer	4.57e-06	6.83e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.57e-06	6.82e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NFKBIA—breast cancer	4.55e-06	6.8e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTP1—breast cancer	4.55e-06	6.8e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP3A4—breast cancer	4.55e-06	6.79e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—TYMS—breast cancer	4.53e-06	6.77e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—HMOX1—breast cancer	4.53e-06	6.76e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.53e-06	6.76e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ITPR1—breast cancer	4.52e-06	6.75e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOTCH1—breast cancer	4.51e-06	6.73e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—HMOX1—breast cancer	4.49e-06	6.71e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ITPR1—breast cancer	4.48e-06	6.69e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PLA2G4A—breast cancer	4.48e-06	6.69e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NCOR1—breast cancer	4.48e-06	6.69e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—breast cancer	4.48e-06	6.69e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP1B1—breast cancer	4.47e-06	6.68e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CG—breast cancer	4.41e-06	6.59e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KIT—breast cancer	4.41e-06	6.59e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—APC—breast cancer	4.41e-06	6.59e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GPX1—breast cancer	4.39e-06	6.56e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HSP90AA1—breast cancer	4.39e-06	6.55e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGF—breast cancer	4.36e-06	6.51e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1A1—breast cancer	4.35e-06	6.5e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ABCB1—breast cancer	4.35e-06	6.49e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ERCC2—breast cancer	4.31e-06	6.44e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ABCB1—breast cancer	4.31e-06	6.44e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GPX1—breast cancer	4.29e-06	6.4e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—TYMS—breast cancer	4.27e-06	6.38e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NCOA1—breast cancer	4.27e-06	6.37e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1A1—breast cancer	4.25e-06	6.34e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—TYMS—breast cancer	4.23e-06	6.32e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK3—breast cancer	4.22e-06	6.31e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NCOR1—breast cancer	4.22e-06	6.3e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PLA2G4A—breast cancer	4.22e-06	6.3e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—breast cancer	4.22e-06	6.3e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ERCC2—breast cancer	4.21e-06	6.29e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—STK11—breast cancer	4.2e-06	6.28e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP19A1—breast cancer	4.2e-06	6.28e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PLA2G4A—breast cancer	4.18e-06	6.25e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—breast cancer	4.18e-06	6.25e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NCOR1—breast cancer	4.18e-06	6.25e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—BRAF—breast cancer	4.15e-06	6.19e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—MTHFR—breast cancer	4.06e-06	6.06e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GPX1—breast cancer	4.04e-06	6.04e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IGF1—breast cancer	4.04e-06	6.03e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT2—breast cancer	4.04e-06	6.03e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EGFR—breast cancer	4.02e-06	6e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GPX1—breast cancer	4.01e-06	5.98e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1A1—breast cancer	4e-06	5.97e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ERCC2—breast cancer	3.97e-06	5.93e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1A1—breast cancer	3.97e-06	5.92e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—MTHFR—breast cancer	3.96e-06	5.91e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.95e-06	5.89e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ERCC2—breast cancer	3.93e-06	5.87e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—COMT—breast cancer	3.91e-06	5.84e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTP1—breast cancer	3.89e-06	5.81e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CD—breast cancer	3.88e-06	5.79e-05	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	3.84e-06	5.73e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—HMOX1—breast cancer	3.84e-06	5.73e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SERPINE1—breast cancer	3.83e-06	5.73e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ITPR1—breast cancer	3.83e-06	5.72e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KRAS—breast cancer	3.8e-06	5.67e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CAV1—breast cancer	3.74e-06	5.59e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—MTHFR—breast cancer	3.73e-06	5.57e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—MTHFR—breast cancer	3.7e-06	5.52e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ABCB1—breast cancer	3.68e-06	5.5e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOS3—breast cancer	3.66e-06	5.47e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CAV1—breast cancer	3.65e-06	5.45e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—TYMS—breast cancer	3.62e-06	5.4e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—breast cancer	3.58e-06	5.34e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NCOR1—breast cancer	3.58e-06	5.34e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PLA2G4A—breast cancer	3.58e-06	5.34e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.57e-06	5.34e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	3.49e-06	5.21e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MDM2—breast cancer	3.47e-06	5.19e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RAF1—breast cancer	3.46e-06	5.17e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—RELA—breast cancer	3.45e-06	5.15e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CAV1—breast cancer	3.44e-06	5.14e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—ERBB2—breast cancer	3.42e-06	5.11e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GPX1—breast cancer	3.42e-06	5.11e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CAV1—breast cancer	3.41e-06	5.09e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CG—breast cancer	3.41e-06	5.09e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP1A1—breast cancer	3.39e-06	5.06e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CB—breast cancer	3.38e-06	5.05e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MTOR—breast cancer	3.38e-06	5.05e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ERCC2—breast cancer	3.36e-06	5.02e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CG—breast cancer	3.33e-06	4.97e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.26e-06	4.87e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CXCL8—breast cancer	3.25e-06	4.85e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HRAS—breast cancer	3.23e-06	4.82e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1B—breast cancer	3.17e-06	4.74e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—MTHFR—breast cancer	3.16e-06	4.72e-05	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—AKT1—breast cancer	3.14e-06	4.68e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CG—breast cancer	3.13e-06	4.68e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CASP3—breast cancer	3.11e-06	4.64e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CG—breast cancer	3.11e-06	4.64e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—breast cancer	3.1e-06	4.63e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL6—breast cancer	3.09e-06	4.61e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCND1—breast cancer	3.03e-06	4.52e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—JUN—breast cancer	3.02e-06	4.51e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CTNNB1—breast cancer	3e-06	4.47e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CD—breast cancer	3e-06	4.47e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—ALB—breast cancer	2.96e-06	4.42e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MMP9—breast cancer	2.94e-06	4.39e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CDKN1A—breast cancer	2.93e-06	4.37e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CD—breast cancer	2.92e-06	4.37e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTEN—breast cancer	2.92e-06	4.36e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CAV1—breast cancer	2.91e-06	4.35e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—ALB—breast cancer	2.89e-06	4.31e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK8—breast cancer	2.86e-06	4.27e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AKT1—breast cancer	2.85e-06	4.25e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NOS3—breast cancer	2.83e-06	4.22e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.78e-06	4.16e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NOS3—breast cancer	2.76e-06	4.12e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.75e-06	4.11e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CD—breast cancer	2.73e-06	4.08e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—ALB—breast cancer	2.72e-06	4.06e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—SRC—breast cancer	2.71e-06	4.04e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—ALB—breast cancer	2.7e-06	4.03e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CG—breast cancer	2.65e-06	3.96e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—breast cancer	2.64e-06	3.94e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—breast cancer	2.61e-06	3.9e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CB—breast cancer	2.61e-06	3.9e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NOS3—breast cancer	2.6e-06	3.88e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS2—breast cancer	2.59e-06	3.86e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NOS3—breast cancer	2.58e-06	3.85e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CB—breast cancer	2.55e-06	3.81e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS2—breast cancer	2.52e-06	3.77e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK3—breast cancer	2.5e-06	3.73e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MYC—breast cancer	2.43e-06	3.62e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TGFB1—breast cancer	2.42e-06	3.62e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.4e-06	3.59e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CB—breast cancer	2.38e-06	3.55e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS2—breast cancer	2.38e-06	3.55e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGFR—breast cancer	2.37e-06	3.54e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS2—breast cancer	2.36e-06	3.52e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CD—breast cancer	2.33e-06	3.49e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—ALB—breast cancer	2.3e-06	3.44e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTEN—breast cancer	2.26e-06	3.37e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KRAS—breast cancer	2.24e-06	3.35e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NOS3—breast cancer	2.2e-06	3.29e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTEN—breast cancer	2.2e-06	3.29e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTEN—breast cancer	2.07e-06	3.1e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CA—breast cancer	2.06e-06	3.08e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTEN—breast cancer	2.06e-06	3.07e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CB—breast cancer	2.03e-06	3.04e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS2—breast cancer	2.02e-06	3.01e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—breast cancer	1.99e-06	2.98e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HRAS—breast cancer	1.91e-06	2.85e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL6—breast cancer	1.82e-06	2.72e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTEN—breast cancer	1.76e-06	2.62e-05	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT1—breast cancer	1.68e-06	2.51e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CA—breast cancer	1.59e-06	2.38e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CA—breast cancer	1.55e-06	2.32e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.46e-06	2.19e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CA—breast cancer	1.45e-06	2.17e-05	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—AKT1—breast cancer	1.3e-06	1.94e-05	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—AKT1—breast cancer	1.27e-06	1.89e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CA—breast cancer	1.24e-06	1.85e-05	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—AKT1—breast cancer	1.2e-06	1.79e-05	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—AKT1—breast cancer	1.19e-06	1.77e-05	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKT1—breast cancer	1.01e-06	1.51e-05	CbGpPWpGaD
